Role of Leu(34)-Met(35) in neurotoxicity caused by human beta-amyloid (1-42) peptide in vitro.
Pákáski
M
M
Department of Neurology and Psychiatry, Albert Szent-Györgyi Medical University, Szeged, Hungary.
Farkas
Z
Z
Soós
K
K
Penke
B
B
Kása
P
P
D000110:Acetylcholinesterase / Q000032:analysis; D016229:Amyloid beta-Peptides / Q000737:chemistry / Q000633:toxicity*; D000818:Animals; D015415:Biomarkers; D002478:Cells, Cultured; D006801:Humans; D007930:Leucine; D008715:Methionine; D009419:Nerve Tissue Proteins / Q000032:analysis; D009474:Neurons / Q000166:cytology / Q000187:drug effects* / Q000473:pathology; D009498:Neurotoxins; D010446:Peptide Fragments / Q000737:chemistry / Q000633:toxicity*; D016548:Prosencephalon / Q000166:cytology*; D051381:Rats; D013329:Structure-Activity Relationship; D013869:Thiolester Hydrolases / Q000032:analysis; D043222:Ubiquitin Thiolesterase; D005680:gamma-Aminobutyric Acid / Q000032:analysis
D016229:Amyloid beta-Peptides; D015415:Biomarkers; D009419:Nerve Tissue Proteins; D009498:Neurotoxins; D010446:Peptide Fragments; C075222:amyloid beta-protein (1-42); D005680:gamma-Aminobutyric Acid; D008715:Methionine; D000110:Acetylcholinesterase; D013869:Thiolester Hydrolases; D043222:Ubiquitin Thiolesterase; D007930:Leucine